Skip to content
Open access

Machine learning-derived Alzheimer’s disease dimensions: neuroanatomical, cognitive, clinical, functional, and genetic risk heterogeneity signatures

Sep 2026 · medRxiv · 0 citations · 56 references
Medicine

TL;DR

Analysis of individual-level summary neuroanatomical signature expression scores revealed that Dimension 1 signature expression correlated strongly with cognitive impairment, clinical severity, functional impairment, and genetic risk, while Dimensional 2 signature expression showed relatively weaker associations.

Abstract

Alzheimer's disease (AD) is characterized by substantial clinical and biological heterogeneity, with diverse neuroanatomical, cognitive, clinical, functional, and genetic risk profiles that are poorly captured by current diagnostic frameworks. Identifying reproducible disease dimensions is critical for understanding divergent pathophysiological mechanisms and designing future stratified therapeutic interventions. Herein, we applied a semi-supervised machine learning clustering framework and robust reproducibility validation strategies to structural MRI data from 1,757 participants, comprising 1,108 cognitively normal controls (CN) and 649 patients with mild cognitive impairment (MCI) or dementia due to AD. We identified two MRI-based neuroanatomical dimensions of AD: Dimension 1 (n = 393; prevalence ~ 61%) and Dimension 2 (n = 256; prevalence ~ 39%). Dimension 1 exhibited widespread cortical and subcortical atrophy, including involvement of the hippocampus, amygdala, parahippocampal, temporal, frontal, and occipital regions, while Dimension 2 showed relatively preserved brain patterns. The two dimensions were not statistically different in demographic characteristics, including age, sex, race, and education (all p > 0.05). Compared to Dimension 2, Dimension 1 had more severe cognitive and clinical impairment, greater functional impairment, elevated APOE {varepsilon}4 carrier burden, and higher polygenic risk for AD (p < 0.05). Analysis of individual-level summary neuroanatomical signature expression scores, quantifying each subject's continuous position along two disease dimensions, revealed that Dimension 1 signature expression correlated strongly with cognitive impairment, clinical severity, functional impairment, and genetic risk, while Dimensional 2 signature expression showed relatively weaker associations. These results reveal that AD encompasses at least two biologically distinct dimensions identifiable from structural MRI profiles and their distinct associations with cognitive, clinical, functional, and genetic profiles. These findings may aid in AD patient stratification for designing targeted therapeutic approaches in the future.

Read PDF

Similar papers

Open access Sep 2026

Spatiotemporal Atrophy Subtypes in Alzheimer's Disease: Neurodegenerative-Vascular Associations and Potential Prognostic Value.

Bomarker-confirmed AD comprised internally reproducible atrophy trajectories with distinct cognitive, vascular, and molecular profiles and may complement fluid biomarkers and conventional volumetry for patient stratification and prognosis.

Chen-Hui Mao, Yu-Yue Qiu, Bo Li et al. · 0 citations
Review Open access Aug 2026

Alzheimer's Disease Detection Techniques: A Review

Recent progress in AI-driven approaches for AD detection is discussed and the importance of interdisciplinary strategies to facilitate earlier diagnosis, improve patient outcomes, and support more effective management of Alzheimer's disease is underscored.

Hakar Hasan Rasheed, Naaman Omar Yaseen · 0 citations
Open access Sep 2026

A Machine Learning Framework for Binary and Multiclass Classification of Cognitive Impairment Using Structural MRI Biomarkers

The findings support the potential role of structural MRI biomarkers combined with interpretable ML approaches for the classification of cognitive impairment and the integration of demographic variables improved model performance, particularly in binary discrimination tasks, whereas multiclass classification remained m...

Alessia Venuto, A. Faraci, Alessandro Grimaldi et al. · 0 citations
Open access Sep 2026

Data-driven subtypes of Alzheimer’s Disease: A multicohort study

These findings, replicated in four diverse and independent datasets, support imaging-based subtyping as a scalable and clinically translatable approach for capturing heterogeneity in AD pathophysiology and associated cognitive trajectories.

A. Metz, Cassandra Polizzi, R. Moqadam et al. · 0 citations
Open access Aug 2026

Interpretable multimodal learning for integrating neuroimaging and genetic data in Alzheimer’s disease

R-GenIMA, an interpretable multimodal large language model that pairs a region-of-interest vision transformer with genetic prompting to jointly analyze structural MRI and single nucleotide polymorphisms, shows that interpretable multimodal AI can integrate imaging and genetics to reveal disease mechanisms.

Kun Zhao, Si-Yuan Dai, Ying-Ying Zhang et al. · 0 citations
Conference

Predicting Cognitive Decline in Healthy Adults using Structural MRI

Alzheimer’s disease (AD) is a progressive neurological disorder and the leading cause of dementia, affecting millions globally. As populations continue to age, AD prevalence is expected to rise significantly, placing substantial burdens on healthcare systems. Early detection of cognitive decline is essential, as interv...

Samaneh Rezaeimanesh, Mohammad Fili, Gui-Ping Hu et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.